Companies reporting w/c 8 February

We give our thoughts on what to expect from companies announcing results week commencing 8 February 2021.

Tuesday

St. Modwen Properties Plc: Q4 2020 Earnings Release

St Modwen is a property company involved in commercial development, housing and investment. The Group specialises in the regeneration of brownfield sites. The market will be looking closely at any comments regarding the latest lockdown and effects on the business.

Ocado Group Plc: Q4 2020 Earnings Release

Ocado’s shares have been trading near record highs in recent days, thanks to the number of people once again turning to online grocery deliveries during the latest lockdown. The Company has seen a big increase in demand over the past year and has been steadily raising its full-year profit guidance. In December, it forecast at least £70m in earnings and its market share has risen since then. Investors will be looking for more detail on how the sale of M&S products is performing and also an update on any new contracts with retailers for the technology side of the business.

Thursday

RELX Plc: Q4 2020 Earnings Release

The Group has some attractive defensive characteristics despite the concerns over its exhibitions business, which has been hit hard as a result of the pandemic. RELX operates in four market segments: Scientific, Technical & Medical, Legal, Exhibitions (London Book Fair) and Risk and Business Analytics. This includes providing digital professional information services to doctors, lawyers and academics. The Group’s priority is the organic development of increasingly sophisticated information-based analytics and decision tools for its customers.

AstraZeneca Plc: Q4 2020 Earnings Release

This has been an extremely eventful year for AstraZeneca, given its position at the forefront in the battle against the virus. Although the Company will not take any profits from the vaccine roll-out, investors will be expecting to hear how this has impacted the costs on the Company’s income. Ahead of the results, the market has priced in a roughly 3% increase in sales and 2% increase in EBITDA. In any case, the results are likely to generate wider media

All information given including prices, yields and our opinion is correct at the time of publication. Our opinions on investments can change at any time and for our latest view please go to www.share.com. To understand how our Investment research team arrive at their views please read our Investment Research Policy.